1887

Chapter 29 : The Road Ahead: a Look at the Future

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

The Road Ahead: a Look at the Future, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815462/9781555814038_Chap29-1.gif /docserver/preview/fulltext/10.1128/9781555815462/9781555814038_Chap29-2.gif

Abstract:

Probiotics may be useful as part of a multipronged strategy to confront malnutrition in the developing world and may be combined with prebiotics, micronutrients, and other foods in global health programs. Future descriptions of probiotics are likely to describe entirely novel classes of microbes as fundamental discoveries are made in the international microbiome project. Beneficial effects of probiotics include the provision of key nutrients for the intestinal mucosa, regulation of cell proliferation and differentiation, and immunomodulation. While probiotics have been studied for the prevention of infections and the suppression of inflammation, new applications and refinements of existing strategies will be based on the science of systems biology. Next-generation probiotics may be selected or engineered to contain such bioconversion features as part of solutions in preventative medicine and therapeutics. Exciting new developments in the understanding of probiotics and the regulation of mucosal immunity are pointing to new directions with respect to selection and engineering of beneficial microbes. Probiotics may also suppress immunity in disorders of chronic inflammation, and such effects may reflect the activation of different immune signaling pathways requiring different types of probiotics for disease amelioration. Advances in comparative and functional genomics are creating new opportunities for rational engineering of different probiotic species. A more detailed understanding is emerging regarding the respective roles of different indigenous and symbiotic microbes in the gastrointestinal tract. Comparative genomics of symbiotic bacterial species has highlighted molecular evolution and its role in niche and habitat adaptation of in the distal human intestine.

Citation: Versalovic J, Wilson M. 2008. The Road Ahead: a Look at the Future, p 393-395. In Versalovic J, Wilson M (ed), Therapeutic Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555815462.ch29

Key Concept Ranking

Lactic Acid Bacteria
0.4704866
0.4704866
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555815462.ch29
1. Burke, W., and, B. M. Psaty. 2007. Personalized medicine in the era of genomics. JAM. 298:16821684.
2. Espinosa, R. M.,, M. Tamez, and, P. Prieto. 2007. Efforts to emulate human milk oligosaccharides. Br. J. Nutr. 98(Suppl. 1):S74–S79.
3. Ewaschuk, J. B.,, J. W. Walker,, H. Diaz,, and K. L. Madsen. 2006. Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice. J. Nutr. 136:14831487.
4. Martin, F. P.,, M. E. Dumas,, Y. Wang,, C. Legido-Quigley,, I. K. Yap,, H. Tang,, S. Zirah,, G. M. Murphy,, O. Cloarec,, J. C. Lindon,, N. Sprenger,, L. B. Fay,, S. Kochhar,, P. van Bladeren,, E. Holmes,, and J. K. Nicholson. 2007. A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol. Syst. Biol. 3:112.
5. Ninonuevo, M. R.,, Y. Park,, H. Yin,, J. Zhang,, R. E. Ward,, B. H. Clowers,, J. B. German,, S. L. Freeman,, K. Killeen,, R. Grimm,, and C. B. Lebrilla. 2006. A strategy for annotating the human milk glycome. J. Agric. Food Chem. 54:74717480.
6. Penner, R., R. N. Fedorak, and, K. L. Madsen. 2005. Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases. Curr. Opin. Pharmacol. 5:596603.
7. Rautava, S., H. Arvilommi, and, E. Isolauri. 2006. Specific probiotics in enhancing maturation of IgA responses in formula-fed infants. Pediatr. Res. 60:221224.
8. Steidler, L., and, P. Rottiers. 2006. Therapeutic drug delivery by genetically modified Lactococcus lactis. Ann. N. Y. Acad. Sci. 1072:176186.
9. Turnbaugh, P. J.,, R. E. Ley,, M. Hamady, C. M. Fraser-Liggett, R. Knight,, and J. I. Gordon. 2007. The human microbiome project. Nature. 449:804810.
10. Xu, J.,, M. A. Mahowald,, R. E. Ley,, C. A. Lozupone,, M. Hamady,, E. C. Martens,, B. Henrissat,, P. M. Coutinho,, P. Minx,, P. Latreille,, H. Cordum,, A. Van Brunt,, K. Kim,, R. S. Fulton,, L. A. Fulton,, S. W. Clifton,, R. K. Wilson,, R. D. Knight,, and J. I. Gordon. 2007. Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol. 5:e156.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error